Elevation Oncology inc (ELEV) Annual Balance Sheets

Annual · GAAP · USD millions
Access ELEV quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Elevation Oncology inc.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent49.46
Marketable Securities, Current SH43.72
Cash & Short-term Investments92.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.54
Total Current Assets94.73
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent0.87
Total Assets95.63
Liabilities
Accounts Payable, Current AC0.56
Accrued Liabilities, Current AC3.91
Total Current Liabilities4.47
Long-term debt31.13
Total Long-term Debt31.13
Other liabilities, Noncurrent0.00
Total Liabilities35.60
Stockholders' Equity
Treasury Stock Common Value-0.11
Common Stock Value0.01
Additional Paid In Capital Common Stock300.52
Retained Earnings / Accumulated Deficit-240.46
Other Equity0.06
Common Stockholder's Equity60.03
Total Stockholder's Equity60.03
Liabilities & Stockholder's Equity95.63
4 historic quarters locked

Sign in to unlock the full Elevation Oncology inc balance sheet history.

About Elevation Oncology Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-002397

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI